Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer

  • Authors:
    • Mei-Ying Liao
    • Mark Yen-Ping Kuo
    • Tung-Ying Lu
    • Yi-Ping Wang
    • Han-Chung Wu
  • View Affiliations

  • Published online on: February 5, 2015     https://doi.org/10.3892/ijo.2015.2876
  • Pages: 1788-1800
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We have generated a novel monoclonal antibody (mAb), OCAb9-1, which specifically binds to various types of cancer cell lines, but not to normal cells. According to the results of immunoaffinity chromatography, LC-MS/MS analysis, co-immunoprecipitation, and RNA interference studies, the target protein of OCAb9-1 is the epithelial cell adhesion molecule (EpCAM). EpCAM is a type I transmembrane glycoprotein which is highly expressed in epithelial-transformed neoplasia and tumor-initiating cells (TICs). However, regulation of EpCAM gene expression in tumors and its role in tumorigenesis are not fully understood. In the present study, we show that EpCAM expression is elevated in several cancer cell lines and tumor tissues. Loss-of-function experiments were performed to demonstrate that EpCAM negatively regulates expression of p53 and p21, and promotes tumor cell growth, colony formation, migration and invasion. The median overall survival of tumor-bearing mice treated with OCAb9-1 was significantly higher than that of PBS-treated mice. Moreover, we report that the interplay between SUZ12 and JMJD3 results in dynamic regulation of lysine 27 trimethylation of histone 3 (H3K27me3). Taken together, our findings suggest that the anti-EpCAM mAb may be suitable for use in cancer diagnosis, prognosis, imaging and therapy. Furthermore, EpCAM overexpression in cancer cells is strongly associated with tumor progression, and may be regulated by epigenetic mechanisms.
View Figures
View References

Related Articles

Journal Cover

April-2015
Volume 46 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liao M, Kuo MY, Lu T, Wang Y and Wu H: Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer. Int J Oncol 46: 1788-1800, 2015
APA
Liao, M., Kuo, M.Y., Lu, T., Wang, Y., & Wu, H. (2015). Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer. International Journal of Oncology, 46, 1788-1800. https://doi.org/10.3892/ijo.2015.2876
MLA
Liao, M., Kuo, M. Y., Lu, T., Wang, Y., Wu, H."Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer". International Journal of Oncology 46.4 (2015): 1788-1800.
Chicago
Liao, M., Kuo, M. Y., Lu, T., Wang, Y., Wu, H."Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer". International Journal of Oncology 46, no. 4 (2015): 1788-1800. https://doi.org/10.3892/ijo.2015.2876